These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Bilici M, Yildirim F, Kandil S, Bekaroğlu M, Yildirmiş S, Değer O, Ulgen M, Yildiran A, Aksu H. Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):181-90. PubMed ID: 14687872 [Abstract] [Full Text] [Related]
10. Iron deficiency in children with attention deficit hyperactivity disorder. Lahat E, Heyman E, Livne A, Goldman M, Berkovitch M, Zachor D. Isr Med Assoc J; 2011 Sep; 13(9):530-3. PubMed ID: 21991711 [Abstract] [Full Text] [Related]
14. Attention-deficit/hyperactivity disorder, Tourette's syndrome, and restless legs syndrome: the iron hypothesis. Cortese S, Lecendreux M, Bernardina BD, Mouren MC, Sbarbati A, Konofal E. Med Hypotheses; 2008 Sep; 70(6):1128-32. PubMed ID: 18164140 [Abstract] [Full Text] [Related]
16. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Adler LA, Liebowitz M, Kronenberger W, Qiao M, Rubin R, Hollandbeck M, Deldar A, Schuh K, Durell T. Depress Anxiety; 2009 Sep; 26(3):212-21. PubMed ID: 19194995 [Abstract] [Full Text] [Related]